Scintigraphic comparison of intra-arterial injection and distal intravenous regional limb perfusion for administration of mesenchymal stem cells to the equine foot.
Authors: Trela J M, Spriet M, Padgett K A, Galuppo L D, Vaughan B, Vidal M A
Journal: Equine veterinary journal
Summary
# Editorial Summary Delivering mesenchymal stem cells (MSCs) effectively to the equine foot remains a technical challenge, with both intra-arterial injection via the median artery and intravenous regional limb perfusion (IVRLP) through the cephalic vein presenting significant practical limitations. Trela and colleagues used scintigraphic imaging to directly compare the distribution patterns and tissue uptake of radiolabelled MSCs administered via these two routes, evaluating whether either technique could reliably target the foot structures where they're therapeutically intended. Their findings revealed that intra-arterial delivery, whilst achieving good initial distribution to distal tissues, carried substantial thrombosis risk—a serious complication that could compromise limb perfusion—whilst intravenous regional perfusion resulted in poor MSC penetration to the foot itself, limiting therapeutic potential. These results highlight that neither technique in its standard form is sufficiently safe or effective for routine clinical application to treat foot pathologies such as navicular disease or deep digital flexor tendinopathy. For practitioners considering stem cell therapy, this work underscores the need for refined injection protocols, alternative delivery sites, or supplementary techniques that can improve both safety margins and target tissue distribution before MSC administration to the foot becomes a reliable clinical option.
Read the full abstract on PubMed
Practical Takeaways
- •Current intra-arterial and intravenous regional limb perfusion techniques for delivering stem cells to the foot have significant limitations and are not yet ready for routine clinical practice
- •Practitioners considering stem cell therapy for distal limb conditions should await further technical refinement to improve safety and efficacy of delivery methods
- •Direct intra-arterial approaches carry thrombosis risk, while peripheral venous approaches fail to achieve adequate distal distribution
Key Findings
- •Intra-arterial regional limb perfusion resulted in arterial thrombosis limiting clinical applicability
- •Intravenous regional limb perfusion showed poor distribution of mesenchymal stem cells to the equine foot
- •Both techniques require modification before safe clinical use for stem cell administration to the equine distal limb